In Serbia, most of the exclusivity arrangements between pharma companies need to be, prior to their implementation, individually exempt by the Serbian Competition Authority (“SCA”). Most recently, the SCA issued two decisions in the individual exemption process. In one it denied, while, in the other it only conditionally approved individual exemptions for exclusive distribution agreements between pharmaceutical companies. These developments show a noticeable shift in the SCA’s stand towards exclusivity arrangements with the SCA taking a stringent approach, limiting the parties' ability to contract exclusivity arrangements in the sector.

NKO Partners has advised Dr. Max on its acquisition of the Miletic Plus pharmacy chain consisting of eight retail units from Biljana Miletic. Sole practitioners Rade Terzic and Milan Cvijovic reportedly advised the seller.

Filip & Company has advised the Centrokinetic orthopedics and medical rehabilitation network together with its shareholder, the Agista investment fund, on their acquisition of a 70% stake in the Socrates clinic in Timisoara, Romania. Timisoara-based sole practitioner Diana Pavel Cios reportedly advised the sellers.

Greenberg Traurig has advised Abris Capital Partners on the sale of Scanmed Group to the American Heart of Poland Group. Rymarz Zdort Maruta advised the American Heart of Poland.

CMS, working with Harneys Cyprus, has advised the European Bank for Reconstruction and Development on a EUR 22 million loan to the Cyprus-based Farmak Group and Ukraine's JSC Farmak for the acquisition of Poland's Symphar and the upgrade of JSC Farmak's IT systems.

Soltysinski Kawecki & Szlezak has advised AniCura AB on its acquisition of Poznan-based veterinary clinic Centrum Zdrowia Malych Zwierzat. Roedl & Partner reportedly advised AniCura as well.